4.7 Review

Neuronanotechnology for brain regeneration

期刊

ADVANCED DRUG DELIVERY REVIEWS
卷 148, 期 -, 页码 3-18

出版社

ELSEVIER
DOI: 10.1016/j.addr.2019.04.004

关键词

Neurogenesis; Brain injury; Nanotechnology; Regenerative medicine; Extracellular matrix; Targeted drug delivery

资金

  1. NIBIB, NIH, United States [R01EB018306]
  2. NINDS, NIH, United States [RO1N5093416, U01NS103882]

向作者/读者索取更多资源

Identifying and harnessing regenerative pathways while suppressing the growth-inhibiting processes of the biological response to injury is the central goal of stimulating neurogenesis after central nervous system (CNS) injury. However, due to the complexity of the mature CNS involving a plethora of cellular pathways and extracellular cues, as well as difficulties in accessibility without highly invasive procedures, clinical successes of regenerative medicine for CNS injuries have been extremely limited. Current interventions primarily focus on stabilization and mitigation of further neuronal death rather than direct stimulation of neurogenesis. In the past few decades, nanotechnology has offered substantial innovations to the field of regenerative medicine. Their nanoscale features allow for the fine tuning of biological interactions for enhancing drug delivery and stimulating cellular processes. This review gives an overview of nanotechnology applications in CNS regeneration organized according to cellular and extracellular targets and discuss future directions for the field. (C) 2019 Published by Elsevier B.V.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据